We dig deep into Alphabet, the tech giant that has become so much more than search, including some hidden gems in the company's portfolio that you may not realize are worth hundreds of billions of dollars.
On Saturday, President Donald Trump signed an executive order directing the U.S. Food and Drug Administration to move faster on reviews tied to psychedelic-based research and treatment, including ibogaine that veteran advocates say may help post-traumatic stress disorder.
Iranian Deputy Foreign Minister Saeed Khatibzadeh has said that Tehran is not prepared to restart in-person negotiations with U.S. officials, arguing Washington is sticking to "maximalist" terms that block progress.
Some financial terms sound scarier than they are. Others sound familiar… right up until you realize you don’t actually know what they mean. If you’ve ever nodded along to financial jargon, hoping nobody would ask a follow-up, this episode is for you.
Elon Musk has argued that federally funded checks delivering a universal high income are his preferred response to job losses tied to artificial intelligence, framing it as an inflation-safe policy if automation expands real output fast enough.
With the social media company's next quarterly update on the horizon, investors are weighing the company's strong top-line momentum against its increasingly expensive AI ambitions.
In a recent post on X, Robin Brooks argued Europe has the tools to squeeze Russia's war finances by stopping seaborne crude shipments leaving the Baltic, saying a U.S.-style cutoff has a track record of forcing exporters to bend.
In this episode, Fool contributors discuss recent financial results from banking giants Bank of America and Charles Schwab and key providers in the semiconductor industry, Taiwan Semiconductor and ASML.
